Anticoagulation module 1: introduction to antithrombotic therapy

Released10 January 2019     Expires: 10 January 2021      Programme: Anticoagulation 1 CPD/CME credit

Sponsorship Statement:

The revision of the anticoagulation modular programme was funded by an educational grant from Bayer. Bayer had no role in the writing of the modules and had no editorial control over the content.

The programme was originally supported by an educational grant from Bristol Myers Squibb (BMS) and Pfizer. BMS and Pfizer had no role in the writing of the modules and had no editorial control over the content.

Designed to give healthcare professionals a clear understanding of the mechanism of coagulation and how this relates to the development of arterial and venous thrombosis. It is one of several modules in our anticoagulation programme.

Module first published: 10 April 2013
First revision: 01 April 2016
Second revision: January 2019

Learning objectives

Upon completing this module, participants should be better able to:

  • Understand the role of Virchow’s triad
  • Discuss the coagulation cascade
  • Recognise key aspects of platelet function
  • Appreciate the consequences of inappropriate activation of coagulation
  • Appreciate the importance of antiplatelet drugs in treating/preventing arterial thrombosis
  • Explain the role of anticoagulants in treating/preventing venous thrombosis and embolism.


Dr Andrew Blann, Consultant Clinical Scientist, City Hospital, Birmingham

First revision (2016) by Dr Matthew Rogers, Locum Consultant Haematologist, Royal Surrey County Hospital, Guildford

Second revision (2019) by Dr Zara Sayar, Haematology Registrar (ST7), University College London Hospitals NHS Foundation Trust


1 CPD/CME credit, 1.0 hour
BJC Learning has assigned one hour of CPD/CME credit to this module

Endorsed by:

You need to login to take this module

You need to be a registered member to view this page. It's quick, free and offers you a host of other benefits, including the facility to print and download articles and supplements, access our archived issues and receive email updates when new issues and other content are online.

110 thoughts on “Anticoagulation module 1: introduction to antithrombotic therapy”

All rights reserved. No part of this programme may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publishers, Medinews (Cardiology) Limited.

It shall not, by way of trade or otherwise, be lent, re-sold, hired or otherwise circulated without the publisher’s prior consent.

Medical knowledge is constantly changing. As new information becomes available, changes in treatment, procedures, equipment and the use of drugs becomes necessary. The editors/authors/contributors and the publishers have taken care to ensure that the information given in this text is accurate and up to date. Readers are strongly advised to confirm that the information, especially with regard to drug usage, complies with the latest legislation and standards of practice.

Healthcare professionals should consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews (Cardiology) Limited cannot accept responsibility for any errors in prescribing which may occur.